1
|
Ambardar S, Howell MC, Mayilsamy K, McGill A, Green R, Mohapatra S, Voronine DV, Mohapatra SS. Ultrafast-UV laser integrating cavity device for inactivation of SARS-CoV-2 and other viruses. Sci Rep 2022; 12:11935. [PMID: 35831374 PMCID: PMC9279343 DOI: 10.1038/s41598-022-13670-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Accepted: 05/26/2022] [Indexed: 11/29/2022] Open
Abstract
Ultraviolet (UV) irradiation-based methods used for viral inactivation have provided an important avenue targeting severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) virus. A major problem with state-of-the-art UV inactivation technology is that it is based on UV lamps, which have limited efficiency, require high power, large doses, and long irradiation times. These drawbacks limit the use of UV lamps in air filtering systems and other applications. To address these limitations, herein we report on the fabrication of a device comprising a pulsed nanosecond 266 nm UV laser coupled to an integrating cavity (LIC) composed of a UV reflective material, polytetrafluoroethylene. Previous UV lamp inactivation cavities were based on polished walls with specular reflections, but the diffuse reflective UV ICs were not thoroughly explored for virus inactivation. Our results show that LIC device can inactivate several respiratory viruses including SARS-CoV-2, at ~ 1 ms effective irradiation time, with > 2 orders of magnitude higher efficiency compared to UV lamps. The demonstrated 3 orders of magnitude cavity enhancement relative to direct exposure is crucial for the development of efficient real-time UV air and water purification systems. To the best of our knowledge this is the first demonstration of LIC application for broad viral inactivation with high efficiency.
Collapse
Affiliation(s)
- Sharad Ambardar
- Department of Medical Engineering, University of South Florida, USF Cherry Drive ISA 6049, Tampa, FL, 33620, USA
| | - Mark C Howell
- Department of Veterans Affairs, James A. Haley Veterans Hospital, Tampa, FL, 33612, USA
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2511, Tampa, FL, 33612, USA
| | - Karthick Mayilsamy
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2525, Tampa, FL, 33612, USA
| | - Andrew McGill
- Department of Veterans Affairs, James A. Haley Veterans Hospital, Tampa, FL, 33612, USA
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2511, Tampa, FL, 33612, USA
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2525, Tampa, FL, 33612, USA
| | - Ryan Green
- Department of Veterans Affairs, James A. Haley Veterans Hospital, Tampa, FL, 33612, USA
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2511, Tampa, FL, 33612, USA
| | - Subhra Mohapatra
- Department of Veterans Affairs, James A. Haley Veterans Hospital, Tampa, FL, 33612, USA.
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2525, Tampa, FL, 33612, USA.
| | - Dmitri V Voronine
- Department of Medical Engineering, University of South Florida, USF Cherry Drive ISA 6049, Tampa, FL, 33620, USA.
- Department of Physics, University of South Florida, Tampa, FL, 33612, USA.
| | - Shyam S Mohapatra
- Department of Veterans Affairs, James A. Haley Veterans Hospital, Tampa, FL, 33612, USA.
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd. MDC 2511, Tampa, FL, 33612, USA.
| |
Collapse
|
2
|
Nabih S, Hassn SS. Nonchemical integration of Au/Ag-based reduced graphene nanohybrid combined with 5-Fluorouracil drug to treat cancer cells. Life Sci 2021; 272:119262. [PMID: 33639151 DOI: 10.1016/j.lfs.2021.119262] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Revised: 02/07/2021] [Accepted: 02/18/2021] [Indexed: 10/22/2022]
Abstract
The perpetual lack of advanced strategies to prevent aggressive breast cancer with multiple categories represents challenging scientific society problems. Reduced graphene oxide- can treat disease, which was recently investigated due to its ability to induce apoptosis-based death. This research tested the chemotherapeutics in vitro efficacy of reduced graphene oxide embedded with gold and silver nanoparticles toward drug-sensitive breast cancer cells (MCF-7) and their cytotoxicity. Synthesis of the Au-Ag/rGO-5FU nanocomposites has been conducted using a wet chemical approach with chitosan aid as a pore directing and capping agent. The particle structure and morphology well characterized using different systems. HR-TEM shows a narrow-sized distribution of less than 100 nm, which is proper for cell membranes and medical use. The physical combination of the nanocomposite and 5-FU drug has been conducted mechanically using wet chemistry. The Au/Ag/rGO-5FU material's high activity enables it to produce reactive oxygen radicals, which display a potential against MCF-7 cell lines. All the results, including those obtained via cytometry, use the combination of Au/Ag/rGO-5FU to show a more substantial anticancer influence and more drug stability than pure 5-FU.
Collapse
Affiliation(s)
- Shimaa Nabih
- Basic Science Departments, Modern Academy for Engineering and Technology, Maadi, Egypt.
| | - Shaymaa Sherif Hassn
- Basic Science Departments, Modern Academy for Engineering and Technology, Maadi, Egypt
| |
Collapse
|